The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …

• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient’s interest …

Sodium–glucose co‐transporter 2 (SGLT2) inhibitors have recently been recommended as
a foundational therapy for patients with heart failure (HF) and reduced ejection fraction (…

Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator) (Netherlands), P.
Christian Schulze (CPG Review Coordinator) (Germany), Magdy Abdelhamid (Egypt), Victor …

Background In most previous epidemiological studies on the prevalence of chronic heart
failure (CHF) the disorder has been defined on clinical criteria. In a cross-sectional survey of …

Objectives: To determine whether specialist nurse intervention improves outcome in patients
with chronic heart failure. Design: Randomised controlled trial. Setting: Acute medical …

Objectives : This study sought to compare catheter ablation with rate control for persistent
atrial fibrillation (AF) in heart failure (HF). Background : The optimal therapy for AF in HF is …

In the originally published version of this manuscript, there were multiple errors in formatting
and content. Figures 1, 2, 4, 5, 6, 12, 19, and 20 have been replaced with corrected versions…

Aims To examine the impact of COVID‐19 on acute heart failure (AHF) hospitalization rates,
clinical characteristics and management of patients admitted to a tertiary Heart Failure Unit …

The management of heart failure (HF) is complex. As a consequence, most cardiology society
guidelines now state that HF care should be delivered in a multiprofessional manner. The …